APPLIED MOLECULAR TRANSPORT (AMTI) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:AMTI • US03824M1099

0.263 USD
-0.04 (-14.3%)
At close: Dec 26, 2023
0.2629 USD
0 (-0.04%)
After Hours: 12/26/2023, 8:00:01 PM
Fundamental Rating

2

Taking everything into account, AMTI scores 2 out of 10 in our fundamental rating. AMTI was compared to 525 industry peers in the Biotechnology industry. The financial health of AMTI is average, but there are quite some concerns on its profitability. AMTI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • AMTI had negative earnings in the past year.
  • AMTI had a negative operating cash flow in the past year.
AMTI Yearly Net Income VS EBIT VS OCF VS FCFAMTI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 -20M -40M -60M -80M -100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -373.95%, AMTI is doing worse than 97.30% of the companies in the same industry.
  • AMTI has a worse Return On Equity (-461.67%) than 80.61% of its industry peers.
Industry RankSector Rank
ROA -373.95%
ROE -461.67%
ROIC N/A
ROA(3y)-70.66%
ROA(5y)-82.71%
ROE(3y)-106.54%
ROE(5y)-110.95%
ROIC(3y)N/A
ROIC(5y)N/A
AMTI Yearly ROA, ROE, ROICAMTI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 -50 -100 -150 -200

1.3 Margins

  • AMTI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AMTI Yearly Profit, Operating, Gross MarginsAMTI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022

More info and screens

5

2. Health

2.1 Basic Checks

  • AMTI has more shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, AMTI has a worse debt to assets ratio.
AMTI Yearly Shares OutstandingAMTI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 10M 20M 30M
AMTI Yearly Total Debt VS Total AssetsAMTI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 50M 100M 150M 200M

2.2 Solvency

  • Based on the Altman-Z score of -36.49, we must say that AMTI is in the distress zone and has some risk of bankruptcy.
  • AMTI has a Altman-Z score of -36.49. This is amonst the worse of the industry: AMTI underperforms 94.94% of its industry peers.
  • AMTI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -36.49
ROIC/WACCN/A
WACCN/A
AMTI Yearly LT Debt VS Equity VS FCFAMTI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 0 50M -50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 4.95 indicates that AMTI has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 4.95, AMTI is in line with its industry, outperforming 50.59% of the companies in the same industry.
  • AMTI has a Quick Ratio of 4.95. This indicates that AMTI is financially healthy and has no problem in meeting its short term obligations.
  • With a Quick ratio value of 4.95, AMTI perfoms like the industry average, outperforming 51.94% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.95
Quick Ratio 4.95
AMTI Yearly Current Assets VS Current LiabilitesAMTI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 50M 100M 150M

More info and screens

1

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 45.09% over the past year.
EPS 1Y (TTM)45.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%73.85%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, AMTI will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.45% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y70.28%
EPS Next 2Y32.75%
EPS Next 3Y14.38%
EPS Next 5Y12.45%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AMTI Yearly Revenue VS EstimatesAMTI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2026 2027 2028 2029 2030 50M 100M
AMTI Yearly EPS VS EstimatesAMTI Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -1 -2 -3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for AMTI. In the last year negative earnings were reported.
  • Also next year AMTI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AMTI Price Earnings VS Forward Price EarningsAMTI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AMTI Per share dataAMTI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5

4.3 Compensation for Growth

  • A more expensive valuation may be justified as AMTI's earnings are expected to grow with 14.38% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.75%
EPS Next 3Y14.38%

More info and screens

0

5. Dividend

5.1 Amount

  • AMTI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

APPLIED MOLECULAR TRANSPORT / AMTI FAQ

Can you provide the ChartMill fundamental rating for APPLIED MOLECULAR TRANSPORT?

ChartMill assigns a fundamental rating of 2 / 10 to AMTI.


What is the valuation status for AMTI stock?

ChartMill assigns a valuation rating of 0 / 10 to APPLIED MOLECULAR TRANSPORT (AMTI). This can be considered as Overvalued.


How profitable is APPLIED MOLECULAR TRANSPORT (AMTI) stock?

APPLIED MOLECULAR TRANSPORT (AMTI) has a profitability rating of 0 / 10.


What is the expected EPS growth for APPLIED MOLECULAR TRANSPORT (AMTI) stock?

The Earnings per Share (EPS) of APPLIED MOLECULAR TRANSPORT (AMTI) is expected to grow by 70.28% in the next year.